THE
GALEN™
PLATFORM

AI-powered Pathology

Automated High-Quality Insights

Meet Galen™, the most widely-deployed AI-powered platform in pathology.

Developed by pathologists for pathologists, Galen is a clinical-grade, multi-tissue platform that helps pathologists detect and grade breast, prostate and gastric cancer, along with more than a hundred other clinically relevant features.

Seamlessly integrated with third party digital pathology software solutions, scanning platforms and laboratory information systems, Galen’s AI-enabled workflows deliver automated high-quality insights that enhance patient safety, increase physician confidence and boost productivity.

Galen serves the world’s leading physicians, health systems and diagnostic service providers. The platform has demonstrated outstanding outcomes in rigorous worldwide clinical studies on multiple scanning systems and staining platforms.

Pathologists

  • Enhanced diagnostic quality
  • Faster results
  • Better patient outcomes
  • Greater confidence
  • Lower workload
  • Streamlined work experience

Patients

  • Improved diagnostic quality
  • Faster results
  • Better clinical outcomes
  • Greater confidence

Providers

  • Better patient outcomes
  • Higher productivity
  • More efficient workflows
  • Improved service quality
  • Greater physician satisfaction
  • Innovative positioning

Industry Partners

  • The broadest AI platform
  • Field-proven technology
  • Validated performance
  • Open API for seamless integration

Prostate

Breast

Gastric

Videos

Validation study at UPMC on an AI-based algorithm for cancer detection

Watch video
Podcasts

Ibex Medical Analytics CTO discusses the AI revolution in Pathology

Listen now
Articles

Ibex’s Chief Scientific Officer on AI-powered cancer diagnostics, company raising $38 Million in series B funding and the future of personalized medicine

Read more

Multiple solutions under the Ibex platform are CE marked (IVDD) and registered with the UK MHRA and ANVISA in Brazil. Ibex's prostate AI solution is also CE marked under IVDR. Ibex's AI platform includes solutions which are for Research Use Only (RUO) in the United States and not cleared by the FDA. Contact us for more information, including indication for use and regulatory approval in other countries.